Clinical Trial

Breast Cancer Clinical Trial 20213097

[LCID Study Number: 20213097]

Evaluation of Novel Blood-Based Biomarkers for Detection of Breast Cancer (EMBRACE)

The purpose of this study is to evaluate the performance of a novel assay to detect biomarkers of breast cancer in women aged 30 to 75 undergoing mammography.

Disease/Condition: Breast Cancer

Department: Translational Lab

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email:

Clinical Trial Details

Protocol #: 20213097

Principal Investigator(s): Kimberly Rieger-Christ

Study Coordinator(s): Sanjna Das

Trial Phase: Sponsor Initiated Study Observational